[This corrects the article DOI: 10.1016/j.omto.2023.100728.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582566 | PMC |
| http://dx.doi.org/10.1016/j.omto.2023.100735 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Author Correction: Ligand-based drug design against Herpes Simplex Virus-1 capsid protein by modification of limonene through in silico approaches.
Sci Rep
May 2024
Department of Biology, Bahir Dar University, P.O. Box 79, Bahir Dar, Ethiopia.
Correction: Complex peptide macrocycle optimization: combining NMR restraints with conformational analysis to guide structure-based and ligand-based design.
J Comput Aided Mol Des
March 2024
Bristol-Myers Squibb Company, Princeton, NJ, USA.
Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments.
Front Immunol
November 2022
Immunology Department, Hospital Cl´ınic de Barcelona, Centre de Diagnòstic Biomèdic (CDB), Barcelona, Spain.
[This corrects the article DOI: 10.3389/fimmu.2022.
View Article and Find Full Text PDFCorrection: Redox-active ligand based Mn(I)-catalyst for hydrosilylative ester reduction.
Chem Commun (Camb)
December 2021
Department of Chemical Sciences, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur Campus, Pin-741246, Nadia, West Bengal, India.
Correction for 'Redox-active ligand based Mn(I)-catalyst for hydrosilylative ester reduction' by Soumi Chakraborty , , 2021, , 12671-12674, DOI: 10.1039/D1CC05614J.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!